Abstract: SA-PO981
Clinical Quality Outcomes in Dialysis Facilities Performing Clinical Research
Session Information
- Hemodialysis and Frequent Dialysis - V
November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 701 Dialysis: Hemodialysis and Frequent Dialysis
Authors
- Mussina, Kurt, Frenova Renal Research, Waltham, Massachusetts, United States
- Rigodon, Vladimir, Frenova Renal Research, Waltham, Massachusetts, United States
- Vienneau, Lori, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Willetts, Joanna, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Chaudhuri, Sheetal, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Reviriego-Mendoza, Marta, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Larkin, John W., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Usvyat, Len A., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Hymes, Jeffrey L., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Kossmann, Robert J., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Maddux, Franklin W., Fresenius Medical Care, Waltham, Massachusetts, United States
Background
Clinical research trials in kidney disease are underperformed compared to most chronic or acute disease states (Giovanni F, et al. JASN 2004). Barriers between stakeholders in clinical trials further impedes its advancement. Uncertainty regarding the impact of clinical trials on quality scores, star ratings, and related reimbursements might be contributing to such hurdles. We compared the profiles of clinical quality scores at a large dialysis organization (LDO) between clinics performing research trials vs those that did not.
Methods
We analyzed data from in-center hemodialysis (HD) patients treated at the LDO from 2016 to 2018. We performed a pooled analysis of the percent of patients achieving targets for the clinical quality measures for: albumin (≥4g/dL), mineral bone disorder (calcium ≤10.0mg/dL, phosphate 3.0-5.5mg/dL, and iPTH 150-600pg/dL), hemoglobin (10-11g/dL), adequacy (kt/V>1.2), diabetic foot checks, missed HD treatments, and catheter use.
Results
We included data from 252 and 2201 facilities with and without clinical research, respectively. We observed no remarkable differences in clinical quality scores for clinics that performed research trials, versus clinics without research (Figure 1).
Conclusion
Findings indicate there are no meaningful differences in clinical quality scores in dialysis facilities conducting research or not. These results are of importance to clinicians and providers considering involvement in clinical research, to advance care paradigms and the state of the art in nephrology.
Funding
- Commercial Support –